About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Texas | 41,989 Studies Near You

Clinical TrialsTexas

Clinical Trials in Texas

Discover 41,989 clinical trials near Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1161-1180 of 41,989 trials

TerminatedST266 Eyedrops for the Treatment of Persistent Corneal Epithelial DefectsThe primary objective is to determine the efficacy of ST266 eye drops in healing persistent epithelial defects (PED).NCT05066698·Dothan, Alabama and 30 others

Find Trials by Condition in Texas

Breast Cancerin Texas Lung Cancerin Texas Prostate Cancerin Texas Colorectal Cancerin Texas Melanomain Texas Leukemiain Texas Lymphomain Texas Pancreatic Cancerin Texas Ovarian Cancerin Texas Brain Cancerin Texas Diabetesin Texas

Data from ClinicalTrials.govTerms

CompletedMotivational Interviewing (MI) Intervention to Improve AdherenceThe purpose of this study is to examine the effectiveness of a telephone motivational interviewing intervention by pharmacy students in enhancing adherence to angiotensin…NCT03985098·Houston, Texas

CompletedGoodwill of Central Texas: Fatherhood Works Healthy Marriage and Responsible Fatherhood Program EvaluationThe key goal of this descriptive evaluation is to assess the extent to which participation in the Fatherhood Works Program is positively associated with improved attitudes and…NCT05292963·Austin, Texas

RecruitingA Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related ComorbiditiesStudy ASC30-301 (AURORA-1) is a Phase III, global, multicenter, randomized, double-blind, placebo-controlled study to investigate the long-term efficacy, safety, and tolerability…NCT07743463·Birmingham, Alabama and 121 others

TerminatedDistal Radius Fracture - Treatment ComparisonThis is a prospective multi-site study. Subjects with distal radius fractures will be enrolled.NCT01883063·Winfield, Illinois and 2 others

RecruitingStudy of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's DiseaseThis study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental decline in the last year and who have P. gingivalis…NCT06847321·Phoenix, Arizona and 38 others

RecruitingPhase 3 Study of LUM-201 in Children With Growth Hormone DeficiencyThe OraGrowtH Phase 3 Trial is a multi-national trial.NCT06948214·Birmingham, Alabama and 50 others

CompletedACT for High-risk PregnancyThis study is designed to reduce the psychological distress of women with high-risk pregnancy.NCT04193514·Dallas, Texas

RecruitingPhase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia PsychosisMulticenter, randomized, 6-week, double-blind, placebo-controlled, parallel-group, Phase 2 study in subjects with LBDP.NCT07029581·Irvine, California and 59 others

CompletedTreatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid DyslexiaThis study will evaluate the effect of atomoxetine in treating Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children and adolescents with ADHD and comorbid reading…NCT00607919·Irvine, California and 15 others

RecruitingThe MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).A prospective multicenter study enrolling high surgical risk patients with severe mitral annular calcification (MAC) and symptomatic mitral valve dysfunction (severe stenosis, ≥…NCT04408430·Gilbert, Arizona and 16 others

CompletedA Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPDThe purpose of this study is to compare Symbicort in a pressurized metered-dose inhaler (pMDI) with formoterol and placebo in the long-term maintenance treatment of patients with…NCT00206167·Birmingham, Alabama and 215 others

CompletedEfficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile PatientsThe primary objective of this study is to evaluate the efficacy of intravenous ibuprofen on reducing fever at 4 hours.NCT01131000·Orlando, Florida and 10 others

CompletedA Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry DiseaseStudy to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of migalastat hydrochloride (HCl) (migalastat) in participants with Fabry disease.NCT00214500·Los Angeles, California and 4 others

CompletedImproving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved ImagingThe goal of this research study is to improve detection of cancer outside of the bladder through genetic testing and improved imaging.NCT02203136·Houston, Texas

Active not recruitingImmunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 TherapyTo compare the effects of a pneumococcal vaccine called PCV20 when given as a single dose versus a boosted regimen to patients who previously received anti-CD20 therapy as…NCT06049134·Houston, Texas

CompletedStudy of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)The goal of this clinical study is to test how well the study drug, brexucabtagene autoleucel (KTE-X19), works in participants with relapsed/refractory (r/r) mantle cell lymphoma…NCT04880434·Gilbert, Arizona and 39 others

CompletedA Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid TumorsThis is a Phase I study designed to evaluate the safety and maximum tolerated dose (MTD) of SGT-94, a novel, tumor-targeted, systemic gene therapy agent for cancer.NCT01517464·Houston, Texas

CompletedSafety and Efficacy of KPI-121 in Subjects With DEDThe primary purpose of this study is to determine the efficacy and safety of KPI-121 0.25% ophthalmic suspension compared to vehicle (placebo) in subjects who have a documented…NCT03616899·Birmingham, Alabama and 80 others

CompletedAn Investigational Immunotherapy Study of BMS-986310 Administered Alone and in Combination With Nivolumab in Patients With Advanced Solid TumorsThe purpose of this study is to determine if BMS-986310 administered in combination with nivolumab, will demonstrate adequate safety and tolerability, as well as a favorable…NCT03661632·St Louis, Missouri and 6 others

PreviousPage 59 of 2100Next

Heart Diseasein Texas